Published in J Grad Med Educ on March 01, 2010
Assessing interpersonal communications skills: the use of standardized patients in graduate medical education. J Grad Med Educ (2013) 0.77
The role of physician specialty board certification status in the quality movement. JAMA (2004) 7.13
Assessment of physician performance in Alberta: the physician achievement review. CMAJ (1999) 4.67
An overview of the uses of standardized patients for teaching and evaluating clinical skills. AAMC. Acad Med (1993) 4.32
Predictive validity of certification by the American Board of Internal Medicine. Ann Intern Med (1989) 3.42
Physician scores on a national clinical skills examination as predictors of complaints to medical regulatory authorities. JAMA (2007) 3.27
Managing the new mandate in resident education: a blueprint for translating a national mandate into local compliance. Ophthalmology (2004) 2.58
The SEGUE Framework for teaching and assessing communication skills. Patient Educ Couns (2001) 2.35
Assessing clinical skills of residents with standardized patients. Ann Intern Med (1986) 2.26
Assessing the ACGME general competencies: general considerations and assessment methods. Acad Emerg Med (2002) 1.73
Developing an institution-based assessment of resident communication and interpersonal skills. Acad Med (2006) 1.57
Validity evidence for an OSCE to assess competency in systems-based practice and practice-based learning and improvement: a preliminary investigation. Acad Med (2008) 1.53
Simulations in the United States Medical Licensing Examination (USMLE). Qual Saf Health Care (2004) 1.46
Do patients and expert doctors agree on the assessment of consultation skills? A comparison of two patient consultation assessment scales with the video component of the MRCGP. Fam Pract (2004) 1.43
Ratings of residents' clinical competence and performance on certification examination. J Med Educ (1987) 1.27
Job turnover and its correlates among residency program directors in internal medicine: a three-year cohort study. Acad Med (2001) 1.14
Beyond fulfilling the core competencies: an objective structured clinical examination to assess communication and interpersonal skills in a surgical residency. Curr Surg (2004) 1.12
Evaluating the Accreditation Council on Graduate Medical Education core clinical competencies: techniques and feasibility in a urology training program. J Urol (2003) 1.09
Primary care residents self assessment skills in dementia. Adv Health Sci Educ Theory Pract (2003) 1.09
Stability of standardized patients' performance in a study of clinical decision making. Fam Med (1995) 1.08
Reliability and validity testing of an evidence-based medicine OSCE station. Fam Med (2009) 1.07
The use of standardized patients within a procedural competency model to teach death disclosure. Acad Emerg Med (2002) 1.07
Development and implementation of an objective structured clinical examination to provide formative feedback on communication and interpersonal skills in geriatric training. J Am Geriatr Soc (2008) 0.99
Assessing the new general competencies for resident education: a model from an emergency medicine program. Acad Med (2001) 0.98
Relationships of ratings of clinical competence and ABIM scores to certification status. Acad Med (1993) 0.90
Evaluating the clinical skills of osteopathic medical students. J Am Osteopath Assoc (2003) 0.90
Teaching the competencies: using objective structured clinical encounters for gastroenterology fellows. Clin Gastroenterol Hepatol (2008) 0.85
An innovative method to assess negotiation skills necessary for quality improvement. Am J Med Qual (2008) 0.83
The use of standardized patients for mock oral board exams in neurology: a pilot study. BMC Med Educ (2006) 0.81
Brief observation: a national study of burnout among internal medicine clerkship directors. Am J Med (2009) 0.80
Evaluation of consultative skills in respiratory medicine using a structured medical consultation. Am J Respir Crit Care Med (1994) 0.77
Use of standardized patients during a psychiatry clerkship. Acad Psychiatry (2006) 0.77
The future of fellowship education in internal medicine. Am J Med (2004) 0.77
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med (2004) 7.67
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med (2013) 2.25
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med (2015) 1.94
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr (2004) 1.65
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64
Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clin Infect Dis (2013) 1.62
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (2006) 1.49
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (2006) 1.38
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (2004) 1.36
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (2006) 1.32
HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS (2011) 1.23
The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr (2007) 1.22
Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (2004) 1.19
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. PLoS One (2012) 1.19
The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis (2011) 1.17
Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology (2004) 1.17
Hyperammonemic encephalopathy caused by carnitine deficiency. J Gen Intern Med (2007) 1.17
Acute hepatitis C virus infection: a chronic problem. Hepatology (2008) 1.15
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis (2004) 1.14
Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol (2007) 1.13
Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol (2005) 1.11
Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc (2002) 1.11
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood (2004) 1.08
Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clin Gastroenterol Hepatol (2004) 1.07
HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology (2006) 1.07
Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci (2010) 1.06
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis (2011) 1.04
Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Med Care (2006) 1.02
Cost-effectiveness of screening for chronic hepatitis C infection in the United States. Clin Infect Dis (2013) 1.00
Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer (2004) 0.99
Nucleoside analogues and mitochondrial toxicity. Clin Infect Dis (2004) 0.98
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine (2005) 0.98
Hepatitis C virus coinfection and superinfection. J Infect Dis (2007) 0.97
The changing epidemiology of liver disease in HIV patients. AIDS Rev (2013) 0.94
CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis (2005) 0.94
Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Curr HIV/AIDS Rep (2012) 0.94
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis (2012) 0.93
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PLoS One (2011) 0.89
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (2005) 0.89
Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia. Clin Gastroenterol Hepatol (2013) 0.88
Management of HBV/HIV-coinfected Patients. Semin Liver Dis (2005) 0.88
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. J Antimicrob Chemother (2009) 0.88
Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis (2009) 0.88
Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol (2008) 0.87
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS (2011) 0.87
Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. J Clin Virol (2009) 0.87
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients. HIV Clin Trials (2012) 0.86
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res (2006) 0.86
Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine (2009) 0.85
Hepatitis C-related arthropathy: Diagnostic and treatment considerations. J Musculoskelet Med (2010) 0.84
Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it. Gastroenterology (2002) 0.84
Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor. Carcinogenesis (2010) 0.84
Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res (2007) 0.83
Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Res (2006) 0.83
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. Clin Infect Dis (2012) 0.83
Extrahepatic manifestations of hepatitis C infection: navigating CHASM. Curr HIV/AIDS Rep (2015) 0.82
Hypercholesterolemia in primary biliary cirrhosis: getting to the heart of the matter? Gastroenterology (2003) 0.82
Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology (2008) 0.81
Low-level HIV infection of hepatocytes. Virol J (2012) 0.81
Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J Clin Densitom (2006) 0.80
Treatment of hepatitis C virus/HIV coinfection. Clin Liver Dis (2005) 0.80
Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg (2012) 0.79
Liver transplantation trends in the HIV population. Dig Dis Sci (2011) 0.79
Epigenetic modification of FOXP3 in patients with chronic HIV infection. J Acquir Immune Defic Syndr (2014) 0.79
Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. J Infect Dis (2004) 0.79
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol (2013) 0.79
Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol (2010) 0.79
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS (2006) 0.79
Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol (2014) 0.78
HIV variability in the liver and evidence of possible compartmentalization. AIDS Res Hum Retroviruses (2011) 0.77
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol (2012) 0.77
Cirrhosis-associated mortality: frankly, scarlet, do we really make a damn? Gastroenterology (2006) 0.77
Liver emergencies during pregnancy. Gastroenterol Clin North Am (2003) 0.76
Can de-bugging the system prevent complications of cirrhosis? The answer may be no. Gastroenterology (2004) 0.76
Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. J Acquir Immune Defic Syndr (2016) 0.76
Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clin Infect Dis (2005) 0.76
Hepatitis delta and HIV infection. AIDS (2017) 0.76
Is it HELLPful to consider the hanging LCHAD in pregnancy-associated liver disease? Gastroenterology (2003) 0.75
Hepatitis C infection with normal transaminases: is the treatment worse than the disease? Gastroenterology (2004) 0.75
A role for the appendix in inflammatory bowel disease? Cut it out. Gastroenterology (2003) 0.75
What is the impact of HIV infection on survival after liver transplantation? Nat Clin Pract Gastroenterol Hepatol (2008) 0.75
Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology (2004) 0.75
Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis. J Acquir Immune Defic Syndr (2016) 0.75
Response to Rigato et al.: bilirubin and non-hepatic disease--a jaundiced view. Trends Mol Med (2005) 0.75
Ironing out the cryptic intestinal defect in hereditary hemochromatosis. Gastroenterology (2005) 0.75
Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. Am J Gastroenterol (2003) 0.75
All kidding aside with the use of lamivudine in children with chronic hepatitis B. Gastroenterology (2002) 0.75
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis (2005) 0.75
Giant cell hepatitis in a teenage woman. Clin Gastroenterol Hepatol (2008) 0.75
Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (2003) 0.75
Some TIPS for the prevention of recurrent variceal hemorrhage? Gastroenterology (2002) 0.75
Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss? Gastroenterology (2006) 0.75